'@maxhodak_ on @NoPriorsPod discusses what comes next for Science, from our PRIMA retinal implant to biohybrid neural interfaces and the future of neural engineering. Thank you @saranormous for the great conversation.
Today marks the European launch of PRIMA, the first and only treatment to be commercially available that restores functional central vision to patients with geographic atrophy caused by dry age-related macular degeneration, a leading cause of blindness.
The first European commercial implant of PRIMA is expected soon.